NIH funding uncertainty affects Bio-Techne guidance.
Steady: 0 in the last 7 days
Updated oct 16
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NIH funding uncertainty affects Bio-Techne guidance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- PDS Biotechnology and the National Cancer Institute entered into a collaborative R&D agreement.Sub-event
NIH funding uncertainty affects Bio-Techne guidance.1 source
Keep exploring
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia
-
Bio-Techne
company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- StockStoryTECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty Life sciences company Bio-Techne (NASDAQ:TECH) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5%